This inventor holds 34 USPTO granted patents and 3 published patent applications, plus 8 CIPO patents and 11 EPO patents, primarily in Sulfonamide Compounds. Top assignees: Pfizer Corporation, Icagen, Inc.. Active years: 1997-2015.
Location History:
- Sandich, GB (1999)
- Broadstaris, GB (1999)
- Kent, GB (2001 - 2010)
- Sandwich, GB (1997 - 2015)
Company Filing History:
34 out of 4,486 
6 out of 102 
Years Active: 1997-2015
Areas of Expertise:
Title: David James Rawson: Innovator in Sulfonamide Compounds
Introduction
David James Rawson, hailing from Sandwich, Great Britain, is a prolific inventor recognized for his significant contributions to the field of medicinal chemistry. With an impressive portfolio of 34 patents, he focuses primarily on developing novel sulfonamide compounds that hold promise in treating a variety of medical conditions, especially pain-related disorders.
Latest Patents
Among his latest innovations are sulfonamide compounds that serve as Nav1.7 inhibitors. These inventions relate to new sulfonamide Nav1.7 inhibitors and their pharmaceutically acceptable salts, underscoring their potential utility in the treatment of numerous disorders. These compounds, along with their compositions, preparation processes, and intermediate substances, are crucial to advancing medical treatments. Another noteworthy patent involves acyl sulfonamide compounds, which also relate to sulfonamide derivatives with similar medical applications. These innovations are designed to provide efficient solutions in pain management and are defined by specific chemical formulas as outlined in the patent descriptions.
Career Highlights
David has worked with notable organizations such as Pfizer Corporation and Icagen, Inc., where he furthered his research in pharmaceutical science. His career in these distinguished companies has allowed him to contribute to groundbreaking developments in drug design and delivery.
Collaborations
Throughout his professional journey, David has collaborated with esteemed colleagues like Nigel Alan Swain and Robert Ian Storer. These partnerships have enabled him to share insights and enhance the innovative process within the realm of medicinal chemistry.
Conclusion
David James Rawson’s dedication to research and innovation in sulfonamide compounds reflects his commitment to advancing medical science. With a robust patent portfolio and significant collaborations, he continues to pave the way for new therapeutic options, particularly in the landscape of pain management. His work exemplifies the intersection of science and invention, promising a brighter future for patients in need of effective treatments.